Brook.ai Secures $28M for AI-Driven Remote Healthcare Expansion
October 18, 2025, 9:38 am
Brook.ai landed $28 million in Series B funding. This investment propels national remote patient care expansion. The platform merges AI with clinical expertise. It delivers continuous, "always-on" support for patients. Proven results include reduced hospital readmissions and improved chronic disease management. UMass Memorial Health led the investment. Morningside also participated. Funds will scale services and technology. The goal: equitable, accessible healthcare transformation across the nation. Brook.ai is redefining patient engagement. It champions proactive health management. This move signifies a pivotal shift in healthcare delivery models. The company aims for widespread impact.
The future of healthcare is arriving. Brook.ai, based in Seattle, WA, just secured a significant $28 million in Series B funding. This capital injection will fuel a nationwide expansion of its remote patient care platform. The company combines artificial intelligence with human clinical expertise. This hybrid approach delivers continuous, personalized care directly to patients’ homes. It marks a critical step forward for digital health.
Traditional healthcare models face immense pressure. Workforce shortages persist. Chronic disease burdens grow. Costs continue to escalate. Brook.ai directly addresses these systemic challenges. Its platform extends care beyond clinic walls. It transforms reactive medicine into proactive health management. This shift benefits patients, providers, and payers alike.
Brook.ai’s approach is unique. It offers an "always-on" care model. This means patients receive constant support and monitoring. AI-driven insights pair with dedicated clinical teams. Together, they guide patients toward better health outcomes. This seamless integration makes healthcare more accessible and effective.
The company's impact is already profound. Partner health systems report dramatic improvements. Congestive heart failure (CHF) readmissions saw a 90% reduction. Hypertensive populations achieved 80% control within just six weeks. These figures demonstrate significant clinical effectiveness. They highlight the platform's ability to drive measurable change.
Patient engagement metrics are equally impressive. Brook.ai boasts an 82% retention rate. Its Net Promoter Score (NPS) sits at 66, rated "excellent." Patient growth soared by 204% over the last year. These numbers underscore strong patient satisfaction and trust in the system. They confirm the platform's user-centric design.
The $28 million funding round was led by UMass Memorial Health. Morningside also contributed significantly. This investment validates Brook.ai’s innovative model. It signals confidence in its national expansion strategy. Strategic capital empowers rapid scaling. It accelerates technological advancements.
Brook.ai plans strategic use of these new funds. Services will expand to include more patient populations. Additional chronic conditions will be targeted. Product and engineering teams will grow. A specific focus remains on safe AI development. This ensures ethical and effective technology use.
Engagement tools and features will see enhancements. This aims for even stronger patient outcomes. Operations will scale up significantly. This supports national expansion efforts. Brook.ai is preparing for broad market adoption. Its infrastructure must support this growth.
At the core of Brook.ai’s system is an AI-enabled health assistant. This assistant is highly sophisticated. It trained on millions of patient conversations over six years. It delivers timely nudges. It offers personalized insights. It provides data-driven recommendations. This AI works in close partnership with human clinical teams.
This hybrid human-AI model is a game-changer. It ensures compassionate, evidence-based care. It improves patient outcomes. It increases patient satisfaction. It strengthens health system return on investment (ROI). Technology supports human care, not replaces it.
Brook.ai empowers providers. It extends their reach into patients' homes. It does so without increasing clinician workload. This is crucial for managing stretched healthcare resources. It allows more patients to receive consistent attention.
Payers also benefit substantially. Brook.ai helps slow disease progression. It improves member health across populations. It significantly reduces costly hospital admissions. This creates a more sustainable and efficient healthcare ecosystem. Value-based care models benefit greatly from this approach.
Healthcare is rapidly shifting towards value-based reimbursement. Care-at-home adoption is accelerating. These trends will intensify ahead of 2026. Brook.ai offers a scalable solution perfectly aligned with this evolution. It addresses urgent industry needs.
Health systems can implement the platform quickly. Integration takes under 30 days. Crucially, it requires zero capital expenditure. This low barrier to entry makes transformation accessible. It offers a cost-efficient path to modernizing care delivery.
Brook.ai is making remote care an integral part of U.S. healthcare. It extends continuity of care. It operates outside traditional practice settings. It delivers measurable improvements in patient outcomes. This comprehensive approach establishes a new standard for remote health.
The company's vision is clear: equitable, accessible care for all. This latest funding brings that vision closer to reality. Brook.ai is not just expanding; it is redefining healthcare. Its blend of technology and human empathy paves a new way forward. The future of health is continuous, connected, and intelligent.
The future of healthcare is arriving. Brook.ai, based in Seattle, WA, just secured a significant $28 million in Series B funding. This capital injection will fuel a nationwide expansion of its remote patient care platform. The company combines artificial intelligence with human clinical expertise. This hybrid approach delivers continuous, personalized care directly to patients’ homes. It marks a critical step forward for digital health.
Traditional healthcare models face immense pressure. Workforce shortages persist. Chronic disease burdens grow. Costs continue to escalate. Brook.ai directly addresses these systemic challenges. Its platform extends care beyond clinic walls. It transforms reactive medicine into proactive health management. This shift benefits patients, providers, and payers alike.
Brook.ai’s approach is unique. It offers an "always-on" care model. This means patients receive constant support and monitoring. AI-driven insights pair with dedicated clinical teams. Together, they guide patients toward better health outcomes. This seamless integration makes healthcare more accessible and effective.
The company's impact is already profound. Partner health systems report dramatic improvements. Congestive heart failure (CHF) readmissions saw a 90% reduction. Hypertensive populations achieved 80% control within just six weeks. These figures demonstrate significant clinical effectiveness. They highlight the platform's ability to drive measurable change.
Patient engagement metrics are equally impressive. Brook.ai boasts an 82% retention rate. Its Net Promoter Score (NPS) sits at 66, rated "excellent." Patient growth soared by 204% over the last year. These numbers underscore strong patient satisfaction and trust in the system. They confirm the platform's user-centric design.
The $28 million funding round was led by UMass Memorial Health. Morningside also contributed significantly. This investment validates Brook.ai’s innovative model. It signals confidence in its national expansion strategy. Strategic capital empowers rapid scaling. It accelerates technological advancements.
Brook.ai plans strategic use of these new funds. Services will expand to include more patient populations. Additional chronic conditions will be targeted. Product and engineering teams will grow. A specific focus remains on safe AI development. This ensures ethical and effective technology use.
Engagement tools and features will see enhancements. This aims for even stronger patient outcomes. Operations will scale up significantly. This supports national expansion efforts. Brook.ai is preparing for broad market adoption. Its infrastructure must support this growth.
At the core of Brook.ai’s system is an AI-enabled health assistant. This assistant is highly sophisticated. It trained on millions of patient conversations over six years. It delivers timely nudges. It offers personalized insights. It provides data-driven recommendations. This AI works in close partnership with human clinical teams.
This hybrid human-AI model is a game-changer. It ensures compassionate, evidence-based care. It improves patient outcomes. It increases patient satisfaction. It strengthens health system return on investment (ROI). Technology supports human care, not replaces it.
Brook.ai empowers providers. It extends their reach into patients' homes. It does so without increasing clinician workload. This is crucial for managing stretched healthcare resources. It allows more patients to receive consistent attention.
Payers also benefit substantially. Brook.ai helps slow disease progression. It improves member health across populations. It significantly reduces costly hospital admissions. This creates a more sustainable and efficient healthcare ecosystem. Value-based care models benefit greatly from this approach.
Healthcare is rapidly shifting towards value-based reimbursement. Care-at-home adoption is accelerating. These trends will intensify ahead of 2026. Brook.ai offers a scalable solution perfectly aligned with this evolution. It addresses urgent industry needs.
Health systems can implement the platform quickly. Integration takes under 30 days. Crucially, it requires zero capital expenditure. This low barrier to entry makes transformation accessible. It offers a cost-efficient path to modernizing care delivery.
Brook.ai is making remote care an integral part of U.S. healthcare. It extends continuity of care. It operates outside traditional practice settings. It delivers measurable improvements in patient outcomes. This comprehensive approach establishes a new standard for remote health.
The company's vision is clear: equitable, accessible care for all. This latest funding brings that vision closer to reality. Brook.ai is not just expanding; it is redefining healthcare. Its blend of technology and human empathy paves a new way forward. The future of health is continuous, connected, and intelligent.